[Diagnostic and therapeutic approach of intraabdominal candidiasis]

A Montero, F Gilsanz, E Maseda1

  • 1Emilio Maseda, Servicio de Anestesia y Reanimación, Hospital Universitario La Paz, Paseo de la Castellana 261; 28046, Madrid, Spain. emilio.maseda@gmail.com.

Insights

Early diagnosis of invasive fungal disease in critical patients improves outcomes. Advanced techniques like PNA-FISH and MALDI-TOF MS aid in rapid, culture-independent detection, guiding timely antifungal treatment.

Area of Science:

  • Critical care medicine
  • Infectious diseases
  • Medical diagnostics

Background:

  • Invasive fungal disease (IFD) significantly increases mortality in critically ill patients.
  • An epidemiological shift in IFD has been observed over recent decades.
  • Timely diagnosis and treatment are crucial for improving patient prognosis.

Purpose of the Study:

  • To highlight the importance of early diagnosis and treatment for invasive fungal disease in critical care.
  • To review novel, culture-independent diagnostic techniques for IFD.
  • To discuss current antifungal therapy recommendations for specific IFD cases.

Main Methods:

  • Review of recent epidemiological data on invasive fungal disease.
  • Evaluation of emerging diagnostic technologies: PNA-FISH, MALDI-TOF MS, nucleic acid assays.
  • Analysis of treatment guidelines for antifungal therapy in critical care.

Main Results:

  • Predictive scores can identify patients who will benefit from early IFD treatment.
  • Culture-independent diagnostic methods show promising results for rapid detection.
  • Echinocandins are recommended for treating Candida peritonitis in critically ill patients.

Conclusions:

  • Early detection and treatment are vital for reducing mortality from invasive fungal disease.
  • New diagnostic approaches offer faster and more accurate identification of fungal pathogens.
  • Optimized antifungal strategies are essential for managing IFD in critical care settings.